专题：Myeloproliferative Neoplasms: Diagnosis and Treatment

This cluster of papers focuses on the molecular pathogenesis, diagnosis, treatment, and prognosis of myeloproliferative disorders such as polycythemia vera, essential thrombocythemia, and myelofibrosis. It covers topics such as JAK2 and CALR mutations, prognostic scoring systems, ruxolitinib therapy, hematologic response, leukemic transformation, and stem cell transplantation.
最新文献
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm

review Full Text OpenAlex

Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: A nationwide longitudinal cohort study

article Full Text OpenAlex

Venetoclax in myeloma: to B, or not to B

editorial Full Text OpenAlex

The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica

article Full Text OpenAlex

Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study

article Full Text OpenAlex

Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes

article Full Text OpenAlex

Clonal hematopoiesis in the setting of hematopoietic cell transplantation

article Full Text OpenAlex

von Willebrand disease: A guide for the internist

article Full Text OpenAlex

Zeb1 maintains long-term adult hematopoietic stem cell function and extramedullary hematopoiesis

article Full Text OpenAlex

Bone mineral density in haemophilia patients: A systematic review and meta‐analysis

review Full Text OpenAlex

近5年高被引文献
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

review Full Text OpenAlex 3359 FWCI601.49233209

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

article Full Text OpenAlex 2497 FWCI564.29196888

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

article Full Text OpenAlex 2261 FWCI507.48103847

The JAK/STAT signaling pathway: from bench to clinic

review Full Text OpenAlex 2056 FWCI140.99835887

Acute myeloid leukemia: current progress and future directions

review Full Text OpenAlex 685 FWCI99.14037921

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

article Full Text OpenAlex 627 FWCI88.92929146

Journal of Thrombosis and Haemostasis

paratext Full Text OpenAlex 557 FWCI0

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

article Full Text OpenAlex 468 FWCI64.60833701

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

article Full Text OpenAlex 435 FWCI58.52649005

Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia

article Full Text OpenAlex 423 FWCI94.98428286